Leucodepletion and the interaction of polymorphonuclear cells with endothelium in systemic inflammatory response syndrome

Brown, K.; Lewis, S.; Hill, T.; Macey, M.; McCarthey, D.; Grant, V.; Treacher, D.
March 2001
Perfusion;Mar2001 Supplement 1, Vol. 16, p75
Academic Journal
The abnormal interaction of polymorphonuclear cells (PMNs) with blood vessel walls is considered to underlie the multiple organ failure of systemic inflammatory response syndrome (SIRS). This consideration is supported by the present finding that PMNs from patients with SIRS are activated, as assessed by an increased distribution of cells bearing CD64, enhanced expression of CD11b and decreased expression of CD62L, and are highly adhesive to endothelial monolayers. Passage of SIRS blood through leucodepletion filters in a laboratory-designed extracorporeal circuit resulted in a marked depletion of PMNs. Of the PMNs that remained in the blood, far fewer cells bound to cultured endothelial cells in comparison with PMNs prior to leucofiltration. We propose that leucofiltration of SIRS blood will limit the number of PMNs available for binding to blood vessel walls and, hence, reduce the pathological manifestations associated with this disorder.


Related Articles

  • In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring. Fenwick, Sean; Roberts, Edward A; Mahesh, Balakrishna S; Roberts, Norman B // Annals of Clinical Biochemistry;Feb2005, Vol. 42 Issue 2, p149 

    The well-described long-term effects of sustained exposure to aluminium in patients with end-stage renal failure (ESRF) are a result of uptake and storage of aluminium, leading to cellular toxicity. A case is presented suggesting that this aluminium may be mobilizable, and indicating the...

  • Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Frühauf, N.; Dumpich, O.; Kaudel, C.; Kasimir-Bauer, S.; Oldhafer, K. // Perfusion;Mar2001 Supplement 1, Vol. 16, p51 

    The clinical use of leukocyte adhesion filters is based on differentiated depletion of blood cells, although most of the mechanisms of filtration are still unclear. There is also evidence that leukocyte adhesion filters can remove disseminated tumour cells from patients' blood. The following...

  • The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass. Treacher, D.; Sabbato, M.; Brown, K.; Gant, V. // Perfusion;Mar2001 Supplement 1, Vol. 16, p67 

    The development of the systemic inflammatory response syndrome (SIRS) is associated with increased morbidity and mortality. Numerous anticytokine trials have failed to demonstrate any outcome benefit and there has been little evidence of improvement in the prognosis of this condition over the...

  • An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients. Besarab, Anatole; Zeig, Steven N.; Martin, Edouard R.; Pergola, Pablo E.; Whittier, Frederick C.; Zabaneh, Raja I.; Schiller, Brigitte; Mayo, Martha; Francisco, Carol A.; Polu, Krishna R.; Duliege, Anne-Marie // BMC Nephrology;2012, Vol. 13 Issue 1, p95 

    Background: Peginesatide is a peptide-based erythropoiesis-stimulating agent that was designed and engineered to stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis. The primary objective of this phase 2 dose-finding study was to determine the once-monthly...

  • A role for plasma removal during sepsis? Grooteman, M. P. C.; Groeneveld, A. B. J.; Grooteman, M P; Groeneveld, A B // Intensive Care Medicine;May2000, Vol. 26 Issue 5, p493 

    Comments on the potential of blood purification techniques as a treatment option for severe sepsis. Role of pro-inflammatory mediators in hemodynamic abnormalities and multiple organ failure; Removal of pro-inflammatory mediators by both filtration and adsorption to the filter membrane; Effect...

  • Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Mariano, Filippo; Tetta, Ciro; Guida, Gianenrico; Triolo, Giorgio; Camussi, Giovanni // Kidney International;Oct2001, Vol. 60 Issue 4, p1598 

    Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Background. Priming of the polymorphonuclear neutrophil (PMN) response has been implicated in the activation of oxidative burst and tissue injury in patients with septic shock and acute renal...

  • Proteolytic enzymes and catabolism: Enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Heidland, August; Hörl, Walter H.; Heller, Norbert; Heine, Hartmut; Neumann, Siegfried; Heidbreder, Ekkehard // Kidney International Supplement;Dec1983, Issue 16, pS27 

    The article reports on the findings of a study of the release of granulocyte proteinases in uremic intoxination and during hemodialysis. According to the article, proteinases act as catalysts in various biological processes such as food digestion, formation of blood clots and fibrinolysis. Types...

  • Effect of Pentoxifylline on the Flow of Polymorphonuclear Leukocytes Through a Model Capillary. Armstrong Jr., Michael; Needham, David; Hatchell, Diane Lillian; Nunn, Rashmi Saxena // Angiology;Apr1990, Vol. 41 Issue 4, p253 

    Pentoxifylline is a methylxanthine derivative used to increase blood flow in peripheral atherosclerosis. Pentoxifylline is known to increase whole blood filtration rate, and recent evidence suggests that pentoxifylline increases the filtration rate of polymorphonuclear leukocytes (PMNs). The...

  • Improvement of brain function in hemodialysis patients treated with erythropoietin. Grimm, Georg; Stockenhuber, Felix; Schneeweiss, Bruno; Madl, Christian; Zeitlhofer, Josef; Schneider, Barbara // Kidney International;Sep1990, Vol. 38 Issue 3, p480 

    To evaluate the effects of recombinant human erythropoietin (rHuEPO) on brain function, 15 chronic hemodialysis patients were studied by event-related P300, stimulus-related evoked potentials, and trailmaking before (hematocrit 22.7%) and after rHuEPO (hematocrit 30.6%). P300 peak latency...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics